Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 6Not yet recruiting 4Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 355Neoplasms 252Carcinoma, Non-Small-Cell Lung 199Colorectal Neoplasms 181Lung Neoplasms 151Prostatic Neoplasms 150Carcinoma, Hepatocellular 127Leukemia, Myeloid, Acute 96Pancreatic Neoplasms 86Multiple Myeloma 82Neoplasm Metastasis 73Recurrence 72Uterine Cervical Neoplasms 68Rectal Neoplasms 68Ovarian Neoplasms 65Stomach Neoplasms 64Triple Negative Breast Neoplasms 59Squamous Cell Carcinoma of Head and Neck 57Brain Neoplasms 56Head and Neck Neoplasms 55Glioblastoma 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Small Cell Lung Carcinoma 48Melanoma 45Endometrial Neoplasms 43Disease 43Esophageal Neoplasms 42Hematologic Neoplasms 41Glioma 41Colonic Neoplasms 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Hypersensitivity × 1 year × Clear all
NCT07572162 2026-05-07

Post-market Safety Study of LUMISIGHT

Lumicell, Inc.

Not yet recruiting
1,500 enrolled
Breast

Anaphylaxis, Breast Neoplasms, Drug Hypersensitivity, Hypersensitivity

NCT07478315 2026-03-17

IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life

Charles LeMoyne Hospital

Phase NA Not yet recruiting
50 enrolled
Breast

Breast Neoplasms, Hypersensitivity

NCT07420036 2026-03-03

SFB6-ZN01 PET

Zhongnan Hospital

Phase EARLY_PHASE1 Not yet recruiting
98 enrolled

Hypersensitivity, Neoplasms

NCT07209774 2025-10-07

Healthspan Connect Programme of Research

King's College London

Not yet recruiting
100,000 enrolled

Psychological Well-Being, Hypersensitivity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡